Italy Sepsis Diagnostics Market Size & Outlook, 2022-2030
Italy sepsis diagnostics market, 2018-2030 (US$M)
Related Markets
Italy sepsis diagnostics market highlights
- The Italy sepsis diagnostics market generated a revenue of USD 33.9 million in 2022 and is expected to reach USD 60.6 million by 2030.
- The Italy market is expected to grow at a CAGR of 7.5% from 2023 to 2030.
- In terms of segment, blood culture media was the largest revenue generating product in 2022.
- Assay Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
Sepsis diagnostics market data book summary
| Market revenue in 2022 | USD 33.9 million |
| Market revenue in 2030 | USD 60.6 million |
| Growth rate | 7.5% (CAGR from 2022 to 2030) |
| Largest segment | Blood culture media |
| Fastest growing segment | Assay Kits & Reagents |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Blood Culture Media, Assay Kits & Reagents, Software |
| Key market players worldwide | BD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress |
Other key industry trends
- In terms of revenue, Italy accounted for 3.4% of the global sepsis diagnostics market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany sepsis diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 82.5 million by 2030.
Blood culture media was the largest segment with a revenue share of 38.94% in 2022. Horizon Databook has segmented the Italy sepsis diagnostics market based on instruments, blood culture media, assay kits & reagents, software covering the revenue growth of each sub-segment from 2018 to 2030.
In Italy, sepsis remains a critical public health issue, with significant implications for patient care and healthcare resources. The prevalence of sepsis in Italy is notably high, reflecting its status as a major cause of morbidity and mortality in hospital settings.
According to a study published by National Library of Medicine in April 2024, the proportion of hospitalizations related to sepsis has steadily increased over time, accounting for 0.65% of all hospital admissions.
The majority of sepsis patients were admitted to nonsurgical and noninfectious disease units, representing 50.3% of these admissions. Analysis based on patient age, Intensive Care Unit (ICU) admission, and the presence of septic shock reveals significant differences in in-hospital mortality rates.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Sepsis Diagnostics Market Scope
Sepsis Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Italy sepsis diagnostics market size, by product, 2018-2030 (US$M)
Italy Sepsis Diagnostics Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
